US2007275092A1PendingUtilityA1

Therapeutic composition supporting the immune system

Individually held — no corporate assignee on recordPriority: Sep 9, 2005Filed: Jul 6, 2007Published: Nov 29, 2007
Est. expirySep 9, 2025(expired)· nominal 20-yr term from priority
Inventors:Julie Buckley
A23L 33/15A61K 31/07A61K 38/063A61K 45/06A61K 31/355A61K 33/04A61P 39/06A23L 33/16A23V 2002/00A61K 33/30A23L 33/10A61K 31/375
46
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed is a therapeutic nutritional compound for treating and supporting the immune response in a mammal, particularly a human baby or child, and the treatment method. Additionally, the therapeutic nutritional compound can be used in conjunction with a vaccine or immunization regimen to reduce the potential undesirable effects caused by other components of the vaccine. The therapeutic nutritional compound can include glutathione, selenium, zinc and antioxidants.

Claims

exact text as granted — not AI-modified
1 . A therapeutic nutritional compound effective in reducing undesirable effects resulting from the presence of metals in vaccines administered to infants, the compound consisting essentially of the following components, on a weight percent basis by weight of the combined components: 
 from about 20% to about 35% glutathione;    less than 1% selenium; and    from about 60% to about 80% of one or more antioxidant vitamins.    
   
   
       2 . The therapeutic nutritional compound of  claim 1 , wherein the compound further includes zinc as a component in an amount less than 1% by weight of the combined components.  
   
   
       3 . The therapeutic nutritional compound of  claim 1 , wherein the antioxidant vitamin is selected from the group consisting of vitamin A, vitamin E, vitamin C and combinations thereof.  
   
   
       4 . The therapeutic nutritional compound of  claim 1 , wherein glutathione is included in an amount of from about 25% to about 30%.  
   
   
       5 . The therapeutic nutritional compound of  claim 1 , wherein the antioxidant vitamin is included in an amount of from 65% to 75%.  
   
   
       6 . The therapeutic nutritional compound of  claim 1 , wherein the one or more antioxidant vitamins comprises, by weight of the combined components: 
 from about 20% to about 30% vitamin A;    from about 2% to about 7% vitamin E; and    from about 35% to about 50% vitamin C.    
   
   
       7 . The therapeutic nutritional compound of  claim 1 , wherein selenium is included in an amount less than 0.1% by weight of the combined components.  
   
   
       8 . The therapeutic nutritional compound of  claim 2 , wherein zinc is included as a component in an amount less than 0.1% by weight of the combined components.  
   
   
       9 . The therapeutic nutritional compound of  claim 5 , wherein the compound further includes zinc as a component in an amount less than 1% by weight of the combined components.  
   
   
       10 . The therapeutic nutritional compound of  claim 5  wherein glutathione is included in an amount of from about 25% to about 30%.  
   
   
       11 . The therapeutic nutritional compound of  claim 5 , wherein selenium is included in an amount less than 0.1% by weight of the combined components.  
   
   
       12 . The therapeutic nutritional compound of  claim 5 , wherein zinc is further included in an amount less than 0.1% by weight of the combined components.  
   
   
       13 . A therapeutic nutritional compound consisting essentially of the following components, on a weight percent basis by weight of the combined components: 
 from about 20% to about 35% glutathione;    less than 1% selenium; and    from about 60% to about 80% of one or more antioxidant vitamins;    wherein said compound is effective in reducing undesirable effects resulting from the presence of metals in vaccines administered to infants when said compound is administered prior to administration of said vaccine.    
   
   
       14 . The therapeutic nutritional compound of  claim 13 , wherein the compound further includes zinc as a component in an amount less than 1% by weight of the combined components.  
   
   
       15 . The therapeutic nutritional compound of  claim 13 , wherein the antioxidant vitamin is selected from the group consisting of vitamin A, vitamin E, vitamin C and combinations thereof.  
   
   
       16 . The therapeutic nutritional compound of  claim 13 , wherein the one or more antioxidant vitamins comprises, by weight of the combined components: 
 from about 20% to about 30% vitamin A;    from about 2% to about 7% vitamin E; and    from about 35% to about 50% vitamin C.    
   
   
       17 . The therapeutic nutritional compound of  claim 14 , wherein the antioxidant vitamin is selected from the group consisting of vitamin A, vitamin E, vitamin C and combinations thereof.  
   
   
       18 . The therapeutic nutritional compound of  claim 14 , wherein the one or more antioxidant vitamins comprises, by weight of the combined components: 
 from about 20% to about 30% vitamin A;    from about 2% to about 7% vitamin E; and    from about 35% to about 50% vitamin C.    
   
   
       19 . A therapeutic nutritional compound effective in reducing undesirable effects resulting from the presence of metals in vaccines administered to infants, the compound consisting of the following components, on a weight percent basis by weight of the combined components: 
 from about 20% to about 35% glutathione;    less than 1% selenium; and    from about 60% to about 80% of one or more antioxidant vitamins.    
   
   
       20 . The therapeutic nutritional compound of  claim 19 , wherein the compound further includes zinc as a component in an amount less than 1% by weight of the combined components.

Join the waitlist — get patent alerts

Track US2007275092A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.